Stephen Lam Chan1, Lin-Lee Wong2,3, Kwan-Chee Allen Chan4, Chit Chow5, Joanna Hung-Man Tong5, Terry Cheuk-Fung Yip6, Grace Lai-Hung Wong6, Charing Ching-Ning Chong7, Po-Hong Liu8,9, Cheuk-Man Chu10, Vincent Wai-Sun Wong6, Ka-Fai To5, Helen L Reeves3,11, Anthony Wing-Hung Chan5. 1. Laboratory of Translational Oncology, Department of Clinical Oncology, Sir YK Pao Centre for Cancer, Institute of Digestive Disease, The Chinese University of Hong Kong, Hong Kong, China. 2. Institute of Cellular Medicine, Newcastle University, Newcastle upon Tyne, United Kingdom. 3. The Liver Unit, Freeman Hospital, Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, United Kingdom. 4. Department of Chemical Pathology, Laboratory of Translational Oncology, Prince of Wales Hospital, The Chinese University of Hong Kong, Hong Kong, China. 5. Department of Anatomical and Cellular Pathology, Laboratory of Translational Oncology, Prince of Wales Hospital, The Chinese University of Hong Kong, Hong Kong, China. 6. Department of Medicine and Therapeutics, Institute of Digestive Disease, State Key Laboratory of Digestive Disease, The Chinese University of Hong Kong, Hong Kong, China. 7. Department of Surgery, The Chinese University of Hong Kong, Hong Kong, China. 8. Department of Medicine, UT Southwestern Medical Center, Dallas, Texas, USA. 9. Faculty of Medicine, National Yang-Ming University School of Medicine, Taipei, Taiwan. 10. Department of Imaging and Interventional Radiology, Prince of Wales Hospital, The Chinese University of Hong Kong, Hong Kong, China. 11. Northern Institute for Cancer Research, Newcastle University, Newcastle upon Tyne, United Kingdom.
Abstract
BACKGROUND: The aim of current study was to (1) construct and validate a novel hepatocellular carcinoma (HCC)-specific inflammatory index; (2) compare the performances of the Integrated Liver Inflammatory Score (ILIS) to existing 4 inflammatory indices in HCC; (3) explore the association between the inflammatory indices and systemic/intratumoral inflammatory markers. METHODS: Two cohorts from Hong Kong (HK; n = 1,315) and Newcastle (n = 574) were studied. A novel index was constructed from the HK training set (n = 627). The index was constructed from the training set by combing independent prognostic circulating parameters, followed by validating in the validation set of HK cohort (n = 688) and the Newcastle cohort. Its prognostic performance was compared to 4 inflammatory indices, namely, the neutrophil to lymphocyte ratio, platelet-to-lymphocyte ratio, prognostic nutrition index, and systemic immune-inflammation index, were compared in the HK cohort. Circulating cytokines and intratumoral gene expression were analyzed in a subset of patients with available samples and correlated with the inflammatory indices. RESULTS: In the training set of the HK cohort, the ILIS, was generated: -0.057 × albumin (g/L) + 0.978 × log (Bilirubin, µmol/L) + 1.341 × log (alkaline phosphatase, IU/L) + 0.086 × Neutrophil (10<sup>9</sup>/L) + 0.301 × log (alpha-fetoprotein, µg/L). With cutoff of 2.60 and 3.87, the ILIS could categorize patients into 3 risk groups in the both validation cohorts. ILIS outperforms other inflammatory indices and remains an independent prognosticator for overall survival after adjustment with Barcelona Clinic Liver Cancer (hazard ratio 31.90, p < 0.001). The ILIS had the best prognostic performances as compared to other inflammatory indices. In exploratory analyses, the ILIS correlated with circulating inflammatory cytokines (e.g., IL-8) but not with any intratumoral inflammatory gene expression. CONCLUSIONS: ILIS is an HCC-specific prognostic index built on 5 readily available blood parameters. Its versatility is validated both Eastern and Western population of HCC. The score is correlated with levels of circulating cytokines.
BACKGROUND: The aim of current study was to (1) construct and validate a novel hepatocellular carcinoma (HCC)-specific inflammatory index; (2) compare the performances of the Integrated Liver Inflammatory Score (ILIS) to existing 4 inflammatory indices in HCC; (3) explore the association between the inflammatory indices and systemic/intratumoral inflammatory markers. METHODS: Two cohorts from Hong Kong (HK; n = 1,315) and Newcastle (n = 574) were studied. A novel index was constructed from the HK training set (n = 627). The index was constructed from the training set by combing independent prognostic circulating parameters, followed by validating in the validation set of HK cohort (n = 688) and the Newcastle cohort. Its prognostic performance was compared to 4 inflammatory indices, namely, the neutrophil to lymphocyte ratio, platelet-to-lymphocyte ratio, prognostic nutrition index, and systemic immune-inflammation index, were compared in the HK cohort. Circulating cytokines and intratumoral gene expression were analyzed in a subset of patients with available samples and correlated with the inflammatory indices. RESULTS: In the training set of the HK cohort, the ILIS, was generated: -0.057 × albumin (g/L) + 0.978 × log (Bilirubin, µmol/L) + 1.341 × log (alkaline phosphatase, IU/L) + 0.086 × Neutrophil (10<sup>9</sup>/L) + 0.301 × log (alpha-fetoprotein, µg/L). With cutoff of 2.60 and 3.87, the ILIS could categorize patients into 3 risk groups in the both validation cohorts. ILIS outperforms other inflammatory indices and remains an independent prognosticator for overall survival after adjustment with Barcelona Clinic Liver Cancer (hazard ratio 31.90, p < 0.001). The ILIS had the best prognostic performances as compared to other inflammatory indices. In exploratory analyses, the ILIS correlated with circulating inflammatory cytokines (e.g., IL-8) but not with any intratumoral inflammatory gene expression. CONCLUSIONS: ILIS is an HCC-specific prognostic index built on 5 readily available blood parameters. Its versatility is validated both Eastern and Western population of HCC. The score is correlated with levels of circulating cytokines.
Authors: Stephen J Bagley; Shawn Kothari; Charu Aggarwal; Joshua M Bauml; Evan W Alley; Tracey L Evans; John A Kosteva; Christine A Ciunci; Peter E Gabriel; Jeffrey C Thompson; Susan Stonehouse-Lee; Victoria E Sherry; Elizabeth Gilbert; Beth Eaby-Sandy; Faith Mutale; Gloria DiLullo; Roger B Cohen; Anil Vachani; Corey J Langer Journal: Lung Cancer Date: 2017-01-25 Impact factor: 5.705
Authors: Stephen L Chan; Anthony W H Chan; Allen K C Chan; Peiyong Jian; Frankie Mo; Charles M L Chan; Kevin Mok; Calvin Liu; Charing C N Chong; Anthony T C Chan; Tony Mok; Winnie Yeo Journal: Liver Int Date: 2016-08-29 Impact factor: 5.828
Authors: Anthony W H Chan; Charing C N Chong; Frankie K F Mo; John Wong; Winnie Yeo; Philip J Johnson; Shuangni Yu; Paul B S Lai; Anthony T C Chan; Ka-Fai To; Stephen L Chan Journal: J Gastroenterol Hepatol Date: 2016-10 Impact factor: 4.029
Authors: Anthony W H Chan; Charing C N Chong; Frankie K F Mo; John Wong; Winnie Yeo; Philip J Johnson; Shuangni Yu; Paul B S Lai; Anthony T C Chan; Ka-Fai To; Stephen L Chan Journal: J Gastroenterol Hepatol Date: 2017-01 Impact factor: 4.029
Authors: P F Ferrucci; S Gandini; A Battaglia; S Alfieri; A M Di Giacomo; D Giannarelli; G C Antonini Cappellini; F De Galitiis; P Marchetti; G Amato; A Lazzeri; L Pala; E Cocorocchio; C Martinoli Journal: Br J Cancer Date: 2015-05-26 Impact factor: 7.640
Authors: Jane Margetts; Laura F Ogle; Stephen L Chan; Anthony W H Chan; K C Allen Chan; David Jamieson; Catherine E Willoughby; Derek A Mann; Caroline L Wilson; Derek M Manas; Winnie Yeo; Helen L Reeves Journal: Br J Cancer Date: 2017-11-09 Impact factor: 7.640
Authors: Jacqueline Estevez; Vincent L Chen; Ondrej Podlaha; Biao Li; An Le; Philip Vutien; Ellen T Chang; Yael Rosenberg-Hasson; Zhaoshi Jiang; Stefan Pflanz; Dongliang Ge; Anuj Gaggar; Mindie H Nguyen Journal: Sci Rep Date: 2017-09-19 Impact factor: 4.379
Authors: Shu-Kui Qin; Qing Li; Jian Ming Xu; Jun Liang; Ying Cheng; Ying Fan; Jun Jiang; Hao Ye; Huimin Tao; Lian Li; Limin Zheng; Zhaohui Wei; Shu Li; Kun Meng; Bin Ye; Yan Sun Journal: Cancer Sci Date: 2020-09-24 Impact factor: 6.716
Authors: Tsz Tung Kwong; Chi Hang Wong; Jing Ying Zhou; Alfred Sze Lok Cheng; Joseph Jao Yiu Sung; Anthony Wing Hung Chan; Stephen Lam Chan Journal: JHEP Rep Date: 2020-12-20